MEGAPRO BIOMEDICAL CO., LTD

Highlights MegaPro Biomedical Co., Ltd

Equities

6827

TW0006827009

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
24.05 ^TWD	-2.04%		0.00%	-1.23%

2022	Megapro Biomedical Co., Ltd Successfully Completes the Biological Evaluations of Iop as Vaccine Adjuvant T Cell Mediated Immunity Is Substantially Enhanced, Improving the Efficacy of Vaccines	CI
2022	Megapro Biomedical Co., Ltd, China Chemical & Pharmaceutical Co., Ltd. and Wellbridge Biotech Ltd. Jointly Establishes an Inhalation Dosage Form Company	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Megapro Biomedical Co., Ltd Successfully Completes the Biological Evaluations of Iop as Vaccine Adjuvant T Cell Mediated Immunity Is Substantially Enhanced, Improving the Efficacy of Vaccines	22-07-25	CI
Megapro Biomedical Co., Ltd, China Chemical & Pharmaceutical Co., Ltd. and Wellbridge Biotech Ltd. Jointly Establishes an Inhalation Dosage Form Company	22-07-14	CI
MegaPro Biomedical, Two Others Form Non-Invasive Drug Development JV	22-07-12	MT
MegaPro Biomedical Co., Ltd. Announces Strategic Cooperation with China Chemical & Pharmaceutical Co	19-12-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW